ArticleFEBS open bio2025
Equi-MOI ratio for rapid baculovirus-mediated multiprotein co-expression in insect cells integrating selenomethionine for structural studies.
Article in FEBS open bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A step further in our commitment to support early career researchers (ECRs).FEBS open bio · 2026Article
- Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor.The Journal of biological chemistry · 2025Article
- Improving experimental reproducibility through comprehensive research protocols.FEBS open bio · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Proteins often co-exist as multicomponent assemblies, making their co-expression essential in recombinant production processes. The baculovirus expression vector system is commonly used to produce recombinant multiprotein complexes mostly for structural and functional studies. Although AI-enhanced tools, such as AlphaFold, have revolutionized protein structure prediction, solving the phase problem remains the most significant challenge in X-ray crystallography for determining entirely novel, dynamic, or complex protein structures. To address this challenge, the early incorporation of selenomethionine into native proteins during production is especially advantageous for facilitating experimental phasing. Here, we describe a fast, effective, and versatile research protocol that uniquely combines these two challenging features. The principle of this method is based on using co-infection of several recombinant baculoviruses in so-called equal multiplicity of infection (MOI) or equi-MOI ratio, while at the same time, the balanced selenomethionine incorporation takes place to allow for an accelerated workflow. The delicate balance between individual conditions for producing selenomethionine-incorporated multiprotein complexes with high efficiency has been developed over several years of studying protein complexes; therefore, many useful tips and tricks are provided as well. Moreover, this protocol is straightforward to implement in any wet lab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.